{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T20:23:16Z","timestamp":1765830196765,"version":"3.48.0"},"reference-count":50,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"unspecified","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"National Institutes of Health - Helping End Addiction Long-term (HEAL) Initiative","award":["UG1DA040316"],"award-info":[{"award-number":["UG1DA040316"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,12,12]]},"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This substudy\u2019s objectives were to (1) examine the transferability of a four archetype framework (simplified pattern of prototypical features) for patients at high risk for opioid use disorder (OUD) developed from a previous study with a similar population; (2) explore how patient preferences for terminology can inform clinician communication strategies for patients with OUD across archetypes and (3) explore how patient perceptions of opioid risks can inform clinician communication strategies across patient archetypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>This qualitative study collected data via semistructured phone interviews with patients about views on opioid-related discussions with primary care clinicians. Qualitative data were coded using the Rigorous and Accelerated Data Reduction technique and analysed via iterative inductive\/deductive thematic analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>40 primary care clinics affiliated with two health systems (site1=Pennsylvania; site2=Minnesota, Wisconsin and North Dakota).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>40 adults meeting one of the following: OUD diagnosis; taking medication for OUD (MOUD) and \u22653 opioid prescriptions in the previous year.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The aforementioned four archetype framework transferred well to the study sample and hinted at archetype differences in participant OUD-terminology preferences and opioid risk perceptions. Two additional archetypes of \u2018in treatment\/recovery for OUD and not taking MOUD\u2019 and \u2018in treatment\/recovery for OUD and taking MOUD\u2019 were identified. Participants best fitting archetypes 1\u20134 preferred clinicians to refrain from using addiction terminology to describe their relationship with opioids, finding the term \u2018dependence\u2019 as more appropriate and a signal that clinicians cared for patients. Participants who best first archetypes 5\u20136 felt \u2018addiction\u2019 was an appropriate, direct term that accurately described their condition, often using it themselves. Patients in all archetypes recognised risks of harm from using opioids, especially participants fitting archetypes 2, 5 and 6 who conveyed the greatest concern.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The modified six archetype framework may help clinicians tailor their communication and care for patients diagnosed with or at high risk for OUD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT04198428\">NCT04198428<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-090462","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T16:26:19Z","timestamp":1736267179000},"page":"e090462","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["\u2018Do they care?\u2019: a qualitative examination of patient perspectives on primary care clinician communication related to opioids in the USA"],"prefix":"10.1136","volume":"15","clinical-trial-number":[{"clinical-trial-number":"nct04198428","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4026-4716","authenticated-orcid":false,"given":"Anthony W","family":"Olson","sequence":"first","affiliation":[{"name":"Research Division, Essentia Institute of Rural Health, Duluth, Minnesota, USA"},{"name":"Department of Pharmacy Practice and Pharmaceutical Sciences, University of Minnesota College of Pharmacy, Duluth, Minnesota, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrei","family":"Bucaloiu","sequence":"additional","affiliation":[{"name":"Center for Pharmacy Innovation and Outcomes, Geisinger, Danville, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clayton I","family":"Allen","sequence":"additional","affiliation":[{"name":"Research Division, Essentia Institute of Rural Health, Duluth, Minnesota, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorraine D","family":"Tusing","sequence":"additional","affiliation":[{"name":"Center for Pharmacy Innovation and Outcomes, Geisinger, Danville, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hillary A","family":"Henzler-Buckingham","sequence":"additional","affiliation":[{"name":"Research Division, Essentia Institute of Rural Health, Duluth, Minnesota, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina M","family":"Gregor","sequence":"additional","affiliation":[{"name":"Center for Pharmacy Innovation and Outcomes, Geisinger, Danville, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura A","family":"Freitag","sequence":"additional","affiliation":[{"name":"Research Division, Essentia Institute of Rural Health, Duluth, Minnesota, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4222-7046","authenticated-orcid":false,"given":"Stephanie A","family":"Hooker","sequence":"additional","affiliation":[{"name":"HealthPartners Institute, Bloomington, Minnesota, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca C","family":"Rossom","sequence":"additional","affiliation":[{"name":"HealthPartners Institute, Bloomington, Minnesota, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5509-1139","authenticated-orcid":false,"given":"Leif I","family":"Solberg","sequence":"additional","affiliation":[{"name":"HealthPartners Institute, Bloomington, Minnesota, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric A","family":"Wright","sequence":"additional","affiliation":[{"name":"Center for Pharmacy Innovation and Outcomes, Geisinger, Danville, Pennsylvania, USA"},{"name":"Department of Bioethics and Decision Sciences, Geisinger, Danville, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina V","family":"Haller","sequence":"additional","affiliation":[{"name":"Research Division, Essentia Institute of Rural Health, Duluth, Minnesota, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrina M","family":"Romagnoli","sequence":"additional","affiliation":[{"name":"Center for Pharmacy Innovation and Outcomes, Geisinger, Danville, Pennsylvania, USA"},{"name":"Department of Population Health Sciences, Geisinger, Danville, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"key":"2025121512181262000_15.1.e090462.1","doi-asserted-by":"crossref","unstructured":"Spencer M , Mini\u00f1o A , Warner M . Drug Overdose Deaths in the United States, 2001\u20132021. 2023;22. doi:10.15620\/CDC:122556","DOI":"10.15620\/cdc:122556"},{"key":"2025121512181262000_15.1.e090462.2","unstructured":"Centers for Disease Control and Prevention. U.S . Overdose deaths decrease in 2023, first time since 2018. national center for health statistics pressroom. 2024. Available: https:\/\/www.cdc.gov\/nchs\/pressroom\/nchs_press_releases\/2024\/20240515.htm#:~:text=The"},{"key":"2025121512181262000_15.1.e090462.3","unstructured":"Council on Foreign Relations . Fentanyl and the U.S. Opioid Epidemic, Available: https:\/\/www.cfr.org\/backgrounder\/fentanyl-and-us-opioid-epidemic"},{"key":"2025121512181262000_15.1.e090462.4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.15909","article-title":"Assessment of Probable Opioid Use Disorder Using Electronic Health Record Documentation","volume":"3","author":"Palumbo","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2025121512181262000_15.1.e090462.5","unstructured":"Dydyk A , Jain N , Gupta M . Opioid use disorder. In: StatPearls. StatPearls Publishing, 2023."},{"key":"2025121512181262000_15.1.e090462.6","unstructured":"Center for Behavioral Health Statistics . Key Substance Use and Mental Health Indicators in the United States: Results from the 2021 National Survey on Drug Use and Health. 2022;EP22\u201307."},{"key":"2025121512181262000_15.1.e090462.7","unstructured":"Centers for Disease Control and Prevention . CDC\u2019s clinical practice guideline for prescribing opioids for pain. opioid prescribing resources. 2022. Available: https:\/\/www.cdc.gov\/opioids\/healthcare-professionals\/prescribing\/guideline\/index.html"},{"key":"2025121512181262000_15.1.e090462.8","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s11606-022-07675-2","article-title":"Integrating Routine Screening for Opioid Use Disorder into Primary Care Settings: Experiences from a National Cohort of Clinics","volume":"38","author":"Austin","year":"2023","journal-title":"J Gen Intern Med"},{"key":"2025121512181262000_15.1.e090462.9","doi-asserted-by":"publisher","DOI":"10.1370\/afm.2908"},{"key":"2025121512181262000_15.1.e090462.10","unstructured":"Agency for Healthcare Research and Quality . Clinicial decision support. 2024 Available: https:\/\/www.ahrq.gov\/cpi\/about\/otherwebsites\/clinical-decision-support\/index.html"},{"key":"2025121512181262000_15.1.e090462.11","doi-asserted-by":"crossref","DOI":"10.1186\/s13722-021-00245-7","article-title":"A pilot study of the functionality and clinician acceptance of a clinical decision support tool to improve primary care of opioid use disorder","volume":"16","author":"Rossom","year":"2021","journal-title":"Addict Sci Clin Pract"},{"key":"2025121512181262000_15.1.e090462.12","doi-asserted-by":"crossref","unstructured":"Bart GB , Saxon A , Fiellin DA , et al . Developing a clinical decision support for opioid use disorders: a NIDA center for the clinical trials network working group report. Addict Sci Clin Pract 2020;15. doi:10.1186\/s13722-020-0180-2","DOI":"10.1186\/s13722-020-0180-2"},{"key":"2025121512181262000_15.1.e090462.13","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2022.107012","article-title":"Design of a pragmatic clinical trial to improve screening and treatment for opioid use disorder in primary care","volume":"124","author":"Rossom","year":"2023","journal-title":"Contemp Clin Trials"},{"key":"2025121512181262000_15.1.e090462.14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/08897077.2015.1129390","article-title":"Assessment of provider attitudes toward #naloxone on Twitter","volume":"37","author":"Haug","year":"2016","journal-title":"Subst Abus"},{"key":"2025121512181262000_15.1.e090462.15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/jphs.12099","article-title":"Perceptions of patient provider agreements","volume":"6","author":"Albrecht","year":"2015","journal-title":"J Pharm Health Serv Res"},{"key":"2025121512181262000_15.1.e090462.16","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000000512"},{"key":"2025121512181262000_15.1.e090462.17","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-021-00423-5"},{"key":"2025121512181262000_15.1.e090462.18","doi-asserted-by":"crossref","DOI":"10.1177\/2381468319892572","article-title":"An Analysis of Primary Care Clinician Communication About Risk, Benefits, and Goals Related to Chronic Opioid Therapy","volume":"4","author":"Danielson","year":"2019","journal-title":"MDM Policy Pract"},{"key":"2025121512181262000_15.1.e090462.19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/08897077.2019.1635956","article-title":"Provider-patient communication about prescription drug abuse: A qualitative analysis of the perspective of prescribers","volume":"41","author":"Mathis","year":"2020","journal-title":"Subst Abus"},{"key":"2025121512181262000_15.1.e090462.20","doi-asserted-by":"publisher","DOI":"10.4278\/0890-1171-12.1.38"},{"key":"2025121512181262000_15.1.e090462.21","doi-asserted-by":"publisher","DOI":"10.1207\/S15324796ABM2304_2"},{"key":"2025121512181262000_15.1.e090462.22","doi-asserted-by":"publisher","DOI":"10.1037\/0003-066X.47.9.1102"},{"key":"2025121512181262000_15.1.e090462.23","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1080\/14659891.2020.1760372","article-title":"The effect of Transtheoretical Model based motivational interviewing on smokeless tobacco cessation in high school students","volume":"25","author":"Ta\u015f","year":"2020","journal-title":"J Subst Use"},{"key":"2025121512181262000_15.1.e090462.24","doi-asserted-by":"publisher","DOI":"10.17294\/2330-0698.1941"},{"key":"2025121512181262000_15.1.e090462.25","doi-asserted-by":"publisher","DOI":"10.36076\/ppj.2008\/11\/S105"},{"key":"2025121512181262000_15.1.e090462.26","doi-asserted-by":"publisher","DOI":"10.1177\/1744987120927206"},{"key":"2025121512181262000_15.1.e090462.27","doi-asserted-by":"publisher","DOI":"10.1007\/BF02766777"},{"key":"2025121512181262000_15.1.e090462.28","doi-asserted-by":"publisher","DOI":"10.5014\/ajot.45.3.214"},{"key":"2025121512181262000_15.1.e090462.29","doi-asserted-by":"publisher","DOI":"10.1007\/s11135-017-0574-8"},{"key":"2025121512181262000_15.1.e090462.30","unstructured":"TranscribeMe Inc . TranscribeMe! 2023."},{"key":"2025121512181262000_15.1.e090462.31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1609406917712131","article-title":"Rapid and Rigorous Qualitative Data Analysis: The \u201cRADaR\u201d Technique for Applied Research","volume":"16","author":"Watkins","year":"2017","journal-title":"Int J Qual Methods"},{"key":"2025121512181262000_15.1.e090462.32","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00240-022-01339-w","article-title":"Decision-making and improvements in health-related quality of life in patients with kidney stones: comparing surgery versus observation using a mixed methods analysis","volume":"50","author":"Forbes","year":"2022","journal-title":"Urolithiasis"},{"key":"2025121512181262000_15.1.e090462.33","doi-asserted-by":"crossref","first-page":"973","DOI":"10.2147\/JMDH.S299765","article-title":"Seeing the Elephant: A Systematic Scoping Review and Comparison of Patient-Centeredness Conceptualizations from Three Seminal Perspectives","volume":"14","author":"Olson","year":"2021","journal-title":"J Multidiscip Healthc"},{"key":"2025121512181262000_15.1.e090462.34","doi-asserted-by":"publisher","DOI":"10.1016\/S0277-9536(00)00098-8"},{"key":"2025121512181262000_15.1.e090462.35","unstructured":"National Institute on Drug Abuse . Words matter: preferred language for talking about addiction. Advanciing addiction science. 2021. Available: https:\/\/nida.nih.gov\/research-topics\/addiction-science\/words-matter-preferred-language-talking-about-addiction#references"},{"key":"2025121512181262000_15.1.e090462.36","doi-asserted-by":"publisher","DOI":"10.1370\/afm.1972"},{"key":"2025121512181262000_15.1.e090462.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2015.12.018"},{"key":"2025121512181262000_15.1.e090462.38","doi-asserted-by":"publisher","DOI":"10.1080\/10410236.2018.1481709"},{"key":"2025121512181262000_15.1.e090462.39","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1080\/07853890.2021.1995623","article-title":"Drug dependence is not addiction-and it matters","volume":"53","author":"Szalavitz","year":"2021","journal-title":"Ann Med"},{"key":"2025121512181262000_15.1.e090462.40","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.163.5.764"},{"key":"2025121512181262000_15.1.e090462.41","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/pme.12862","article-title":"Emergency Department Patient Perspectives on the Risk of Addiction to Prescription Opioids","volume":"17","author":"Conrardy","year":"2016","journal-title":"Pain Med"},{"key":"2025121512181262000_15.1.e090462.42","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.drugpo.2012.01.012","article-title":"\u201cI\u2019m not afraid of those ones just 'cause they\u2019ve been prescribed\u201d: perceptions of risk among illicit users of pharmaceutical opioids","volume":"23","author":"Daniulaityte","year":"2012","journal-title":"Int J Drug Policy"},{"key":"2025121512181262000_15.1.e090462.43","article-title":"A systematic review of chronic pain patients\u2019 perceptions of prescription opioids","volume":"4","author":"McDonnell","year":"2020","journal-title":"M Perit"},{"key":"2025121512181262000_15.1.e090462.44","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2217\/pmt-2021-0072","article-title":"Patient perspectives from the multi-disciplinary chronic pain clinic: a qualitative study","volume":"12","author":"Pandey","year":"2022","journal-title":"Pain Manag"},{"key":"2025121512181262000_15.1.e090462.45","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2217\/pmt-2023-0048","article-title":"Lessons learned from the chronic pain clinic: a qualitative study of the perspectives of healthcare providers","volume":"13","author":"Pandey","year":"2023","journal-title":"Pain Manag"},{"key":"2025121512181262000_15.1.e090462.46","doi-asserted-by":"publisher","DOI":"10.1370\/afm.2920"},{"key":"2025121512181262000_15.1.e090462.47","doi-asserted-by":"publisher","DOI":"10.1370\/afm.2757"},{"key":"2025121512181262000_15.1.e090462.48","unstructured":"Common comorbidities with substance use disorders research. 2020. Available: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK571451\/"},{"key":"2025121512181262000_15.1.e090462.49","article-title":"How Social Relationships Influence Substance Use Disorder Recovery: A Collaborative Narrative Study","volume":"13","author":"Pettersen","year":"2019","journal-title":"Subst Abuse"},{"key":"2025121512181262000_15.1.e090462.50","doi-asserted-by":"crossref","unstructured":"Rottnek F , Bello-Kottenstette JK . The Impact of Social and Structural Determinants on Depression, Prescription Opioid Use, Opioid Misuse, and Opioid Use Disorder. Pain, the Opioid Epidemic, and Depression 2024;117\u201337. doi:10.1093\/9780197675250.003.0007","DOI":"10.1093\/9780197675250.003.0007"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-090462","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T20:18:22Z","timestamp":1765829902000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-090462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,7]]},"published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1136\/bmjopen-2024-090462"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-090462","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2025,1]]}}}